These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype. Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087 [TBL] [Abstract][Full Text] [Related]
24. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788 [TBL] [Abstract][Full Text] [Related]
25. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study. Kim J; Gianferante M; Karyadi DM; Hartley SW; Frone MN; Luo W; Robison LL; Armstrong GT; Bhatia S; Dean M; Yeager M; Zhu B; Song L; Sampson JN; Yasui Y; Leisenring WM; Brodie SA; de Andrade KC; Fortes FP; Goldstein AM; Khincha PP; Machiela MJ; McMaster ML; Nickerson ML; Oba L; Pemov A; Pinheiro M; Rotunno M; Santiago K; Wegman-Ostrosky T; Diver WR; Teras L; Freedman ND; Hicks BD; Zhu B; Wang M; Jones K; Hutchinson AA; Dagnall C; Savage SA; Tucker MA; Chanock SJ; Morton LM; Stewart DR; Mirabello L JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 34308104 [TBL] [Abstract][Full Text] [Related]
26. Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients. Zhong X; Dong Z; Dong H; Li J; Peng Z; Deng L; Zhu X; Sun Y; Lu X; Shen F; Su X; Zhang L; Gu Y; Zheng H PLoS One; 2016; 11(6):e0156789. PubMed ID: 27257965 [TBL] [Abstract][Full Text] [Related]
27. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256 [TBL] [Abstract][Full Text] [Related]
28. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations. Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil. Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148 [TBL] [Abstract][Full Text] [Related]
30. Germline Variants Incidentally Detected via Tumor-Only Genomic Profiling of Patients With Mesothelioma. Mitchell OD; Gilliam K; Del Gaudio D; McNeely KE; Smith S; Acevedo M; Gaduraju M; Hodge R; Ramsland ASS; Segal J; Das S; Hathaway F; Bryan DS; Tawde S; Galasinski S; Wang P; Tjota MY; Husain AN; Armato SG; Donington J; Ferguson MK; Turaga K; Churpek JE; Kindler HL; Drazer MW JAMA Netw Open; 2023 Aug; 6(8):e2327351. PubMed ID: 37556141 [TBL] [Abstract][Full Text] [Related]
31. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing. Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. Stadler ZK; Maio A; Chakravarty D; Kemel Y; Sheehan M; Salo-Mullen E; Tkachuk K; Fong CJ; Nguyen B; Erakky A; Cadoo K; Liu Y; Carlo MI; Latham A; Zhang H; Kundra R; Smith S; Galle J; Aghajanian C; Abu-Rustum N; Varghese A; O'Reilly EM; Morris M; Abida W; Walsh M; Drilon A; Jayakumaran G; Zehir A; Ladanyi M; Ceyhan-Birsoy O; Solit DB; Schultz N; Berger MF; Mandelker D; Diaz LA; Offit K; Robson ME J Clin Oncol; 2021 Aug; 39(24):2698-2709. PubMed ID: 34133209 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study. Arrieta O; Caballé-Pérez E; Hernández-Pedro N; Romero-Nuñez E; Lucio-Lozada J; Castillo-Ruiz C; Acevedo-Castillo K; María Álvarez-Gómez R; Molina-Garay C; Jiménez-Olivares M; Carrillo-Sánchez K; Cristina Mendoza-Caamal E; Cardona AF; Remon J; Alaez-Verson C Lung Cancer; 2024 Aug; 194():107864. PubMed ID: 38945003 [TBL] [Abstract][Full Text] [Related]
34. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. Samadder NJ; Riegert-Johnson D; Boardman L; Rhodes D; Wick M; Okuno S; Kunze KL; Golafshar M; Uson PLS; Mountjoy L; Ertz-Archambault N; Patel N; Rodriguez EA; Lizaola-Mayo B; Lehrer M; Thorpe CS; Yu NY; Esplin ED; Nussbaum RL; Sharp RR; Azevedo C; Klint M; Hager M; Macklin-Mantia S; Bryce AH; Bekaii-Saab TS; Sekulic A; Stewart AK JAMA Oncol; 2021 Feb; 7(2):230-237. PubMed ID: 33126242 [TBL] [Abstract][Full Text] [Related]
35. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma. Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490 [TBL] [Abstract][Full Text] [Related]
36. Survey of germline variants in cancer-associated genes in young adults with colorectal cancer. Mikaeel RR; Young JP; Li Y; Smith E; Horsnell M; Uylaki W; Tapia Rico G; Poplawski NK; Hardingham JE; Tomita Y; Townsend AR; Feng J; Zibat A; Kaulfuß S; Müller C; Yigit G; Wollnik B; Price TJ Genes Chromosomes Cancer; 2022 Feb; 61(2):105-113. PubMed ID: 34761457 [TBL] [Abstract][Full Text] [Related]
37. Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes. Mossanen M; Nassar AH; Stokes SM; Martinez-Chanza N; Kumar V; Nuzzo PV; Kwiatkowski DJ; Garber JE; Curran C; Freeman D; Preston M; Mouw KW; Kibel A; Choueiri TK; Sonpavde G; Rana HQ Clin Genitourin Cancer; 2022 Dec; 20(6):568-574. PubMed ID: 36127252 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259 [TBL] [Abstract][Full Text] [Related]
39. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes. Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J; Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971 [TBL] [Abstract][Full Text] [Related]
40. Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes. Wong W; Lowery MA; Berger MF; Kemel Y; Taylor B; Zehir A; Srinivasan P; Bandlamudi C; Chou J; Capanu M; Varghese A; Yu KH; Iacobuzio-Donahue CA; Shia J; Klimstra DS; Jarnagin WR; Stadler ZK; O'Reilly EM Cancer; 2019 May; 125(9):1441-1448. PubMed ID: 30620386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]